Early research from the 1990s to the early 2000s concentrated on foundational biological studies and clinical exploration, with topics such as eosinophil cationic protein, systemic lupus erythematosus, and drug interactions reflecting an emphasis on understanding disease mechanisms, pharmacological complexities, and baseline clinical efficacy. The gene discussed is RNASE3; the disease is systemic lupus erythematosus.